New hope for Tough-to-Treat breast cancer: Two-Drug combo enters trial
NCT ID NCT07235618
Summary
This study is testing whether adding a drug called entinostat to standard fulvestrant therapy can help control advanced breast cancer that has started growing again after previous hormone-based treatments. It will enroll about 50 women to see if this combination can delay cancer progression and improve survival. Researchers will also check if a simple blood test can predict who is most likely to benefit from this treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED OR METASTATIC BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, 510060, China
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.